Investment will modernize and expand Jubilant Radiopharma's Kirkland facility, strengthen Canada's life sciences sector and support high-quality jobs in Quebec

KIRKLAND, QC, Oct. 8, 2026 /CNW/ -- At a time of economic uncertainty as tariffs reshape the global trade landscape, the Government of Canada is investing in the capacity to produce, innovate and manufacture critical biomedical products at home and strengthen the country's domestic supply chains.

Today, the Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, announced a Strategic Response Fund (SRF) investment of $23.8 million in Jubilant Radiopharma Inc. to modernize and expand its biomanufacturing facility in Kirkland, Quebec, to help meet the growing demand for radiopharmaceutical products.

This investment will support Jubilant Radiopharma's $94.5 million project to upgrade its Kirkland facility and establish it as a global centre of excellence for radiopharmaceutical production and research and development (R&D). The project will modernize production lines, create new production spaces and upgrade laboratory, storage and shipping areas for key radiopharmaceutical products. The project will also create and maintain 225 high-quality jobs in Quebec and support 35 co-op placements for students. It will also strengthen collaborations with Canadian universities, research institutions and small and medium-sized enterprises, focusing on areas such as artificial intelligence–assisted diagnostics and nuclear medicine research. This investment builds on Canadian strengths in medical isotopes and supports the growth of the domestic value chains.

Quotes

"Canada needs a strong and resilient life sciences sector that can develop, manufacture and deliver the critical health products Canadians depend on. The Government of Canada's investment in Jubilant Radiopharma will strengthen radiopharmaceutical production in Quebec, support high-quality jobs and help ensure Canada has the domestic capacity and expertise needed to respond to growing health needs. By supporting the production of critical biopharmaceutical products at home, the government is strengthening the country's economy and health security."
– The Honourable Mélanie Joly, Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions

"The radiopharmaceutical and life sciences industries help build our economy and save lives. Today's investment will enable Quebec and Canada to remain global leaders in the field of radioisotopes."
– The Honourable Marjorie Michel, Minister of Health

"This investment recognizes Jubilant Radiopharma's innovation capabilities in Nuclear Medicine and the important role our sector plays in advancing both diagnostic and therapeutic treatments. This project will build our deep capability here in Quebec, create and secure high-value jobs, and ensure a reliable supply of essential radiopharmaceutical products in Canada and around the world."
– Harsher Singh, CEO, Jubilant Radiopharma

Quick facts

• Since 2020, the Government of Canada has made investments of more than $2.5 billion in 43 projects in the biomanufacturing, vaccine and therapeutics ecosystem, strengthening domestic pandemic response capabilities and life sciences innovation. These investments are helping grow industrial capabilities, enhance R&D, infrastructure and manufacturing capacity, and build expertise.
• Jubilant Radiopharma is a subsidiary of India-based Jubilant Pharma Limited, an established leader in the global radiopharmaceutical industry with extensive experience in successfully executing large-scale R&D and investment projects.
• The Strategic Response Fund (SRF) helps Canadian industries innovate, adapt and compete in a changing global economy. The SRF supports large-scale, transformative projects that build economic resilience, strengthen supply chains and protect good jobs in key sectors such as steel, aluminum, automotive, forest products, artificial intelligence and advanced technologies.

Associated links

• Jubilant Radiopharma Inc.
• Strategic Response Fund
• Canada's Biomanufacturing and Life Sciences Strategy

Stay connected

Find more services and information on the Innovation, Science and Economic Development Canada website.

Follow Innovation, Science and Economic Development Canada on social media.
X (Twitter): @ISED_CA | Facebook: Canadian Innovation | Instagram: @cdninnovation | LinkedIn: Innovation, Science and Economic Development Canada

SOURCE Innovation, Science and Economic Development Canada